A recent study found that a single dose of LSD effectively treated symptoms of anxiety for an astonishing 12 weeks.

A first-of-its-kind Canadian trial is testing psilocybin, the psychedelic component found in magic mushrooms, on participants ...

Researchers in Kingston, Ont., are embarking upon a clinical trial that will look at whether very small doses of psilocybin — ...

According to results of a phase 2 study of PSX-001, the psilocybin-assisted treatment for generalized anxiety disorder led to ...

LifeStance Health reports Xanax provides quick anxiety relief but is not suitable for long-term use; alternatives and therapy ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage pharmaceutical company developing innovative combination therapies for high-impact medical conditions, today announced that it has received an ...

Research presented at APNA 2025 explores a nurse-led interpersonal psychotherapy (IPT) initiative to manage depression and anxiety in pregnant and postpartum women. Evidence shows that both group and ...

Pittsburgh: Viatris Inc., a global healthcare company, has announced it has acquired Aculys Pharma, Inc., a clinical-stage ...

Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric disorders, today announced the appointment of Timothy Noyes as President and ...

Your mental health is just as important as your physical well-being. Some people get the calling to study and work with the ...

Cybin faces clinical trial delays, leadership changes, and cash burn concerns. Learn why CYBN's outlook has been downgraded ...